Yazan AlHabil

Dr. Yazan AlHabil


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2025 in Clinical Therapeutics
Verified
Journal Article
Closed access
YAYazan AlHabil
Yazan AlHabil
LSLiza Saadeddin
Liza Saadeddin
HIHana Ishkirat
Hana Ishkirat
MAMariam Alqam
Mariam Alqam
OHObada Hossoon
Obada Hossoon
HMHanadi Mosa
Hanadi Mosa

8 January 2025 in BMC Neurology
Verified
Journal Article
Open access
PDF file
YAYazan AlHabil
Yazan AlHabil
KAKhulood Al-Sayed
Khulood Al-Sayed
ASAshraf Salameh
Ashraf Salameh
Trigeminal neuralgia (TN) is a prevalent and debilitating craniofacial pain disorder characterized by severe, unilateral, shock-like pain. Standard treatments include anti-epileptic drugs and surgical interventions, but many patients experience limited relief or adverse effects. Non-invasive therapies, such as transcutaneous electrical nerve stimulation (TENS), have emerged as alternative options. This systematic review and meta-analysis aimed to evaluate the efficacy of TENS in managing primary trigeminal neuralgia. A comprehensive search of PubMed, Cochrane Library, and Google Scholar was conducted, yielding 89 papers. Following selection criteria, five clinical trials involving 101 patients with primary TN and TENS treatment were included. Data on pain severity, TENS parameters, and outcomes were extracted. Statistical analysis was performed using RevMan software, with outcomes assessed using Visual Analogue Scale (VAS) scores before and after TENS treatment. Pre-treatment VAS scores averaged 8.75 ± 0.18, indicating severe pain. Post-treatment, the mean VAS score significantly decreased to 1.17 ± 0.55, demonstrating substantial pain relief. The meta-analysis revealed a mean difference of 7.49 (95% CI: 7.05 to 7.93) in VAS scores, with a p-value < 0.05, indicating statistically significant pain reduction. Heterogeneity among studies was moderate (I2 = 57%). Complications were infrequently reported, with one study noting paresthesia in a small number of patients. TENS appears to be an effective and safe intervention for reducing pain in patients with primary trigeminal neuralgia. Despite variability in treatment protocols and follow-up periods, the overall evidence supports TENS as a viable option for managing TN pain. Future research should focus on standardizing TENS protocols and evaluating long-term efficacy and safety.

25 August 2022 in Research Square
Verified
Preprint
Open access
PDF file
FAFaten Amer
Faten Amer
HNHaroun Neiroukh
Haroun Neiroukh
SASa’ed Enan Abuzahra
Sa’ed Enan Abuzahra
YAYazan AlHabil
Yazan AlHabil
MAMufeeda Afifi
Mufeeda Afifi
DEDóra Endrei
Dóra Endrei
Introduction The balanced scorecard (BSC) was implemented to improve hospitals’ performance evaluations (PE) in the last 30 years. BSC consists of six perspectives: financial, customer, internal, external, knowledge and growth, and managerial. However, patients were seldom engaged in such implementations. This research aims to engage Palestinian patients in BSC implementations. Methodology This is a cross-sectional study. We collected data between January and October 2021 using the printed BSC-PATIENT survey. We evaluated the patients’ experiences and attitudes toward BSC dimensions (BSCP ATT). The differences in evaluations based on admission status were also analyzed using the Mann‒Whitney U test. Additionally, we analyzed the causal relationships between patients’ experiences and attitudes using multiple linear regression, and the multicollinearity of the model was tested. Finally, the path analysis was performed to understand the BSC strategic maps based on the Palestinians’ evaluations. Results The mean scores for Palestinian patient experiences evaluation showed that the services experience factor had the highest score (87.7 ± 17.7), and the patient care experience factor had the lowest score (57 ± 34.5). The patient experiences collectively predicted 56.4% of the variance in the BSCP ATT. The experiences factors of information (β = 0.400, t = 13.543, P < 0.001), patient care (β = 0.241, t = 8.061, P < 0.001), services (β = 0.176, t = 6.497, P < 0.001), and building (β = 0.177, t = 6.308, P < 0.001) had the highest impact on BSCP ATT. The price had only a weak negative influence (β=-0.051, t=-2.040, P = 0.042). Accessibility to hospitals did not have any impact on BSCP ATT. Significant differences between inpatient and outpatients’ evaluations in regard to experiences related to patient care (P = 0.042), services (P < 0.001), accessibility (P < 0.001), and BSCP ATT (P = 0.003) were found. Conclusion Managers of Palestinian hospitals should prioritize enhancing the patient experience, particularly the information experience. The importance of patient education programs and information sharing with patients cannot be overstated. Other experiences as patient care, services, and building are also significant. By focusing on separate evaluations of patients' experiences and attitudes, the BSC strategic maps will be easier to understand from the patients' point of view. BSC-PATIENT survey may assist hospitals managers in achieving this objective and enhancing their action plans. Palestinian hospitals must enhance patients’ feedback and engagement culture.

30 April 2026 in Journal of Neuroimmunology
Verified
Journal Article
Open access
KZKhaled Zammar
Khaled Zammar
ASAbeer Safan
Abeer Safan
DADareen Jamal Abushalbak
Dareen Jamal Abushalbak
ADAdam Daromar
Adam Daromar
BCBeatriz Canibano
Beatriz Canibano
SHShahd Hamid
Shahd Hamid
Monoclonal antibodies have transformed the treatment of neuromyelitis optica spectrum disorder (NMOSD), yet their comparative efficacy by aquaporin-4 immunoglobulin G (AQP4-IgG) serostatus remains uncertain. We conducted a systematic review and meta-analysis to compare monoclonal antibody efficacy between AQP4-IgG seropositive and seronegative NMOSD patients. We searched PubMed/MEDLINE, Embase, and Cochrane CENTRAL from inception through January 2025 for studies comparing monoclonal antibody efficacy outcomes (rituximab, eculizumab, satralizumab, inebilizumab, tocilizumab, or ravulizumab) between seropositive and seronegative NMOSD patients. Primary outcomes included annualized relapse rate (ARR) and relapse events. Secondary outcomes included disability progression (Expanded Disability Status Scale [EDSS]) and infectious adverse events. Random-effects meta-analysis was performed. The protocol was registered in PROSPERO (CRD1049290). Thirteen studies (4 randomized controlled trials [RCTs], 9 observational) comprising 1284 patients (1010 seropositive; 274 seronegative) were included. Seropositive patients had significantly lower relapse risk (risk ratio [RR] = 0.66; 95% CI: 0.49-0.89; p = 0.007; I2 = 0%; 9 studies), indicating 34% greater efficacy in preventing relapses. An RCT-only subgroup analysis demonstrated a 59% relative risk reduction favoring seropositive patients (RR = 0.41; 95% CI: 0.25-0.69; p = 0.0008; I2 = 0%). No significant differences were observed for continuous ARR (standardized mean difference [SMD] = 0.23; p = 0.61; I2 = 94%), disability progression (SMD = 1.07; p = 0.32; I2 = 96%), or infectious adverse events (RR = 1.13; p = 0.61; I2 = 0%). Monoclonal antibodies demonstrate significantly greater efficacy in preventing relapses in AQP4-IgG seropositive compared with seronegative NMOSD patients. Serostatus should inform treatment selection and expectations. Comparable safety profiles support continued use in seronegative patients, though further research is needed to optimize therapeutic strategies for this population.

3 February 2024 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
YAYazan AlHabil
Yazan AlHabil
QDQasem N Dola
Qasem N Dola
AKAbdelatif Khader
Abdelatif Khader
Cancers of unknown primary (CUPs) pose diagnostic and therapeutic challenges because of their aggressive nature and elusive identification through conventional diagnostic means. This case report presents a unique finding in a 57-year-old female patient who, alongside her CUP, developed a cavernous mesenteric lymphangioma—a rare lymphatic malformation that is more commonly observed in pediatric populations. The interrelation between CUPs, chylous ascites, and lymphangiomas is explored, shedding light on this uncommon occurrence. Our patient’s journey began with a CUP diagnosis, marked by metastatic adenocarcinoma. Subsequent symptoms led to the discovery of a mesenteric lymphangioma. The case unfolds the patient’s diagnostic challenges, surgical interventions, and postoperative course. By highlighting the distinctive features of our case, we aim to contribute to the limited understanding of the interplay between lymphatic malformations and metastatic malignancies.

4 September 2024 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
YAYazan AlHabil
Yazan AlHabil
AOAnas N. Owda
Anas N. Owda
BZBasil J. Zaid
Basil J. Zaid
SHSeema Hameedi
Seema Hameedi
LSLiza Saadeddin
Liza Saadeddin
MAMohammad A.A Awad
Mohammad A.A Awad
Inadequate surgical interventions can lead to serious complications such as tubo-ovarian abscesses in the upper female genital system, often resulting from untreated pelvic inflammatory disease. Pelvic inflammatory disease, caused by infections like Chlamydia trachomatis and Neisseria gonorrhoeae, leads to scarring and adhesions in the reproductive organs, with common risk factors including intrauterine device use and multiple sexual partners. Pelvic inflammatory disease primarily affects sexually active young women and can manifest with varied symptoms, potentially leading to complications like ectopic pregnancy, infertility, and chronic pelvic pain if untreated. This case report presents a unique scenario involving a 17-year-old sexually inactive female who experienced concurrent tubo-ovarian abscess, acute cystitis, and pancolitis following laparoscopic ovarian cystectomy. Pelvic inflammatory disease and its complications are well-documented, but the simultaneous occurrence of acute cystitis and pancolitis in this context is unprecedented in the medical literature. The patient’s presentation, clinical course, and management are detailed, highlighting the importance of considering diverse and severe complications in individuals with a history of gynecological surgeries. Our case report highlights the need for healthcare professionals to remain vigilant for atypical presentations of gynecological complications and emphasizes the value of interdisciplinary collaboration for optimal patient care. We encourage further research and awareness to enhance understanding and recognition of complex clinical scenarios associated with gynecological procedures.